Genotyping and Antiretroviral Drug Resistance Mutations among HIV Patients in Southern Santa Catarina, Brazil
-
Published:2024-08-13
Issue:
Volume:22
Page:
-
ISSN:1570-162X
-
Container-title:Current HIV Research
-
language:en
-
Short-container-title:CHR
Author:
Esmeraldino Mendes Marcon Chaiana1,
Daiane Schlindwein Aline1,
de Macedo Brigido Luis Fernando2,
Ibette Lopez-Lopes Giselle2,
Bastos Cabral Gabriela2,
Schuelter-Trevisol Fabiana1ORCID
Affiliation:
1. Postgraduate Program in Health Sciences. University of Southern Santa Catarina at Tubarão, Santa Catarina, Brazil
2. Adolfo Lutz Institute, São Paulo, Brazil
Abstract
Introduction:
Therapeutic measures have been successful in increasing survival rates
and quality of life of HIV/AIDS-infected people. However, some people fail to respond to antiretroviral
therapy (HAART) because of viral resistance-associated mutations.
Objective:
To identify virus genotype and the presence of mutations that alter the susceptibility to
HAART, and factors associated with the occurrence of these mutations.
Method:
A cross-sectional study was conducted on adults living with HIV attending a specialized
outpatient clinic in southern Santa Catarina, Brazil. The participants were interviewed and had
blood samples collected for analysis. Those with detectable viral load were genotyped.
Results:
Out of the 629 patients recruited, 127 subjects were included due to having a detectable
viral load. The most common mutations were M184V and K103N. HIV-1 subtype C was the most
prevalent strain. Resistance to HAART was associated with modification in the treatment regimen
(p <0.001).
Conclusion:
This study concluded that the circulating subtype virus was subtype C and that the
mutations K103N and M184V were the most prevalent strains in southern Santa Catarina, Brazil.
Publisher
Bentham Science Publishers Ltd.